Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them
    4.
    发明授权
    Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them 失效
    呋喃羰基胍衍生物,其制备方法和含有它们的药物组合物

    公开(公告)号:US07351843B2

    公开(公告)日:2008-04-01

    申请号:US10581799

    申请日:2004-12-24

    CPC分类号: C07D307/68

    摘要: The present invention relates to furancarbonylguanidine derivatives, a preparation method thereof and a pharmaceutical composition comprising the same.Furancarbonylguanidine derivatives of the present invention inhibit NHE-1 (sodium-hydrogen exchanger isoform 1), which helps recovery of heart function damaged from ischemia/reperfusion and decreases myocardial infarction rate, indicating that they have protective effect on myocardial cells. Thus, furancarbonylguanidine derivatives of the present invention can be effectively used for the prevention and the treatment of ischemic heart diseases such as myocardial infarction, arrhythmia, angina pectoris, etc, and also a promising candidate for a heart protecting agent applied to reperfusion therapy including thrombolytics or cardiac surgery including coronary artery bypass graft, percutaneous transluminal coronary angioplasty, etc.

    摘要翻译: 本发明涉及呋喃羰基胍衍生物,其制备方法和包含其的药物组合物。 本发明的呋喃羰基胍衍生物抑制NHE-1(钠氢交换异构体1),其有助于恢复从缺血/再灌注损伤的心脏功能,并降低心肌梗死率,表明它们对心肌细胞具有保护作用。 因此,本发明的呋喃羰基胍衍生物可以有效地用于预防和治疗心肌梗死,心律失常,心绞痛等缺血性心脏病,也是应用于再灌注治疗的心脏保护剂的有希望的候选物,包括溶栓剂 或心脏手术,包括冠状动脉旁路移植术,经皮腔内冠状动脉血管成形术等